Kobayashi Hidetsugu, Uchino Shigehiko, Takinami Masanori, Uezono Shoichi
Intensive Care Unit, Department of Anesthesiology, Jikei University School of Medicine, Tokyo, Japan.
Department of Anesthesiology, Jikei University School of Medicine, Tokyo, Japan.
Respir Care. 2017 Nov;62(11):1379-1386. doi: 10.4187/respcare.05073. Epub 2017 Jul 18.
The Centers for Disease Control and Prevention recently released a surveillance definition for respiratory complications in ventilated patients, ventilator-associated events (VAEs), to replace ventilator-associated pneumonia (VAP). VAEs consist of ventilator-associated conditions (VAC), infection-related ventilator-associated complications (IVAC), and possible VAP. A duration of mechanical ventilation of at least 4 d is required to diagnose VAE. However, the observed duration of mechanical ventilation was < 4 d in many previous studies. We evaluated the impact of VAEs on clinical outcomes in critically ill subjects who required mechanical ventilation for ≥ 4 d.
This single-center retrospective cohort study was conducted in the general ICU of an academic hospital. We included 407 adult subjects who were admitted to the ICU and required mechanical ventilation for at least 4 d. VAC and IVAC were identified from the electronic medical records. VAP was defined according to the Centers for Disease Control and Prevention 2008 criteria and was identified from the surveillance data of the infection control team of our hospital. Clinical outcomes were studied in the VAC, IVAC, and VAP groups. Possible VAP was not investigated.
Higher mortality was seen in VAC and IVAC subjects, but not in VAP subjects, compared with those without VAEs and VAP. By multivariable hazard analysis for hospital mortality, IVAC was independently associated with hospital mortality (hazard ratio 2.42, 95% CI 1.39-4.20, = .002). VAC also tended to show a similar association with hospital mortality (hazard ratio 1.45, 95% CI 0.97-2.18, = .07). On the other hand, VAP did not increase a hazard of hospital death (hazard ratio 1.08, 95% CI 0.44-2.66, = .87).
We found that a VAE was related to hospital mortality in critically ill subjects with prolonged mechanical ventilation, and that VAP was not.
美国疾病控制与预防中心最近发布了一项针对机械通气患者呼吸并发症的监测定义,即呼吸机相关性事件(VAE),以取代呼吸机相关性肺炎(VAP)。VAE包括呼吸机相关性状况(VAC)、感染相关的呼吸机相关性并发症(IVAC)以及可能的VAP。诊断VAE需要机械通气至少4天。然而,在许多先前的研究中,观察到的机械通气时间<4天。我们评估了VAE对需要机械通气≥4天的危重症患者临床结局的影响。
这项单中心回顾性队列研究在一家教学医院的综合重症监护病房进行。我们纳入了407名入住重症监护病房且需要机械通气至少4天的成年患者。从电子病历中识别VAC和IVAC。VAP根据美国疾病控制与预防中心2008年标准定义,并从我院感染控制团队的监测数据中识别。对VAC、IVAC和VAP组的临床结局进行了研究。未对可能的VAP进行调查。
与无VAE和VAP的患者相比,VAC和IVAC患者的死亡率更高,但VAP患者并非如此。通过对医院死亡率进行多变量风险分析,IVAC与医院死亡率独立相关(风险比2.42,95%CI 1.39 - 4.20,P = 0.002)。VAC也倾向于显示出与医院死亡率有类似的关联(风险比1.45,95%CI 0.97 - 2.18,P = 0.07)。另一方面,VAP并未增加医院死亡风险(风险比1.08,95%CI 0.44 - 2.66,P = 0.87)。
我们发现,VAE与机械通气时间延长的危重症患者的医院死亡率相关,而VAP则不然。